Multigene predictors of tacrolimus exposure in kidney transplant recipients

Rebecca A. Pulk, David S. Schladt, William S. Oetting, Weihua Guan, Ajay K. Israni, Arthur J. Matas, Rory P. Remmel, Pamala A. Jacobson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aim: Determine the effect of the genetic variants beyond CYP3A5∗3 on tacrolimus disposition. Patients & methods: We studied genetic correlates of tacrolimus trough concentrations with POR∗28, CYP3A4∗22 and ABCC2 haplotypes in a large, ethnically diverse kidney transplant cohort (n = 2008). Results: Subjects carrying one or more CYP3A5∗1 alleles had lower tacrolimus trough concentrations (p = 9.2 × 10-75). The presence of one or two POR∗28 alleles was associated with a 4.63% reduction in tacrolimus trough concentrations after adjusting for CYP3A5∗1 and clinical factors (p = 0.037). In subset analyses, POR∗28 was significant only in CYP3A5∗3/∗3 carriers (p = 0.03). The CYP3A4∗22 variant and the ABBC2 haplotypes were not associated. Conclusion: This study confirmed that CYP3A5∗1 was associated with lower tacrolimus trough concentrations. POR∗28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity. CYP3A4∗22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations. Original submitted 19 December 2014; Revision submitted 2 April 201.

Original languageEnglish (US)
Pages (from-to)841-854
Number of pages14
JournalPharmacogenomics
Volume16
Issue number8
DOIs
StatePublished - Jul 1 2015

Fingerprint

Tacrolimus
Kidney
Haplotypes
Alleles
Cytochrome P-450 CYP3A
Transplant Recipients
Transplants
Enzymes

Keywords

  • ABCC2
  • POR
  • calcineurin inhibitor
  • cytochrome P450 3A4 and 3A5
  • kidney transplant
  • pharmacogenomics
  • pharmacokinetics
  • tacrolimus

Cite this

Multigene predictors of tacrolimus exposure in kidney transplant recipients. / Pulk, Rebecca A.; Schladt, David S.; Oetting, William S.; Guan, Weihua; Israni, Ajay K.; Matas, Arthur J.; Remmel, Rory P.; Jacobson, Pamala A.

In: Pharmacogenomics, Vol. 16, No. 8, 01.07.2015, p. 841-854.

Research output: Contribution to journalArticle

@article{5d063e95bf1f4638a1f4311831e42672,
title = "Multigene predictors of tacrolimus exposure in kidney transplant recipients",
abstract = "Aim: Determine the effect of the genetic variants beyond CYP3A5∗3 on tacrolimus disposition. Patients & methods: We studied genetic correlates of tacrolimus trough concentrations with POR∗28, CYP3A4∗22 and ABCC2 haplotypes in a large, ethnically diverse kidney transplant cohort (n = 2008). Results: Subjects carrying one or more CYP3A5∗1 alleles had lower tacrolimus trough concentrations (p = 9.2 × 10-75). The presence of one or two POR∗28 alleles was associated with a 4.63{\%} reduction in tacrolimus trough concentrations after adjusting for CYP3A5∗1 and clinical factors (p = 0.037). In subset analyses, POR∗28 was significant only in CYP3A5∗3/∗3 carriers (p = 0.03). The CYP3A4∗22 variant and the ABBC2 haplotypes were not associated. Conclusion: This study confirmed that CYP3A5∗1 was associated with lower tacrolimus trough concentrations. POR∗28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity. CYP3A4∗22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations. Original submitted 19 December 2014; Revision submitted 2 April 201.",
keywords = "ABCC2, POR, calcineurin inhibitor, cytochrome P450 3A4 and 3A5, kidney transplant, pharmacogenomics, pharmacokinetics, tacrolimus",
author = "Pulk, {Rebecca A.} and Schladt, {David S.} and Oetting, {William S.} and Weihua Guan and Israni, {Ajay K.} and Matas, {Arthur J.} and Remmel, {Rory P.} and Jacobson, {Pamala A.}",
year = "2015",
month = "7",
day = "1",
doi = "10.2217/pgs.15.42",
language = "English (US)",
volume = "16",
pages = "841--854",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "8",

}

TY - JOUR

T1 - Multigene predictors of tacrolimus exposure in kidney transplant recipients

AU - Pulk, Rebecca A.

AU - Schladt, David S.

AU - Oetting, William S.

AU - Guan, Weihua

AU - Israni, Ajay K.

AU - Matas, Arthur J.

AU - Remmel, Rory P.

AU - Jacobson, Pamala A.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Aim: Determine the effect of the genetic variants beyond CYP3A5∗3 on tacrolimus disposition. Patients & methods: We studied genetic correlates of tacrolimus trough concentrations with POR∗28, CYP3A4∗22 and ABCC2 haplotypes in a large, ethnically diverse kidney transplant cohort (n = 2008). Results: Subjects carrying one or more CYP3A5∗1 alleles had lower tacrolimus trough concentrations (p = 9.2 × 10-75). The presence of one or two POR∗28 alleles was associated with a 4.63% reduction in tacrolimus trough concentrations after adjusting for CYP3A5∗1 and clinical factors (p = 0.037). In subset analyses, POR∗28 was significant only in CYP3A5∗3/∗3 carriers (p = 0.03). The CYP3A4∗22 variant and the ABBC2 haplotypes were not associated. Conclusion: This study confirmed that CYP3A5∗1 was associated with lower tacrolimus trough concentrations. POR∗28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity. CYP3A4∗22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations. Original submitted 19 December 2014; Revision submitted 2 April 201.

AB - Aim: Determine the effect of the genetic variants beyond CYP3A5∗3 on tacrolimus disposition. Patients & methods: We studied genetic correlates of tacrolimus trough concentrations with POR∗28, CYP3A4∗22 and ABCC2 haplotypes in a large, ethnically diverse kidney transplant cohort (n = 2008). Results: Subjects carrying one or more CYP3A5∗1 alleles had lower tacrolimus trough concentrations (p = 9.2 × 10-75). The presence of one or two POR∗28 alleles was associated with a 4.63% reduction in tacrolimus trough concentrations after adjusting for CYP3A5∗1 and clinical factors (p = 0.037). In subset analyses, POR∗28 was significant only in CYP3A5∗3/∗3 carriers (p = 0.03). The CYP3A4∗22 variant and the ABBC2 haplotypes were not associated. Conclusion: This study confirmed that CYP3A5∗1 was associated with lower tacrolimus trough concentrations. POR∗28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity. CYP3A4∗22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations. Original submitted 19 December 2014; Revision submitted 2 April 201.

KW - ABCC2

KW - POR

KW - calcineurin inhibitor

KW - cytochrome P450 3A4 and 3A5

KW - kidney transplant

KW - pharmacogenomics

KW - pharmacokinetics

KW - tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=84937000548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937000548&partnerID=8YFLogxK

U2 - 10.2217/pgs.15.42

DO - 10.2217/pgs.15.42

M3 - Article

C2 - 26067485

AN - SCOPUS:84937000548

VL - 16

SP - 841

EP - 854

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 8

ER -